Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Immunity, Humoral"" wg kryterium: Temat


Tytuł :
Associations between markers of cellular and humoral immunity to rubella virus following a third dose of measles-mumps-rubella vaccine.
Autorzy :
Crooke SN; Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.
Ovsyannikova IG; Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.
Kennedy RB; Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.
Warner ND; Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
Poland GA; Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2020 Nov 25; Vol. 38 (50), pp. 7897-7904. Date of Electronic Publication: 2020 Nov 04.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Immunity, Cellular*
Immunity, Humoral*
Measles-Mumps-Rubella Vaccine/*administration & dosage
Measles-Mumps-Rubella Vaccine/*immunology
Rubella/*immunology
Adult ; Chemokines/immunology ; Chemokines/metabolism ; Cytokines/immunology ; Cytokines/metabolism ; Female ; Humans ; Immunization Schedule ; Leukocytes, Mononuclear/immunology ; Leukocytes, Mononuclear/metabolism ; Middle Aged ; Rubella/prevention & control ; Young Adult
Czasopismo naukowe
Tytuł :
Analysis of Humoral Immune Responses in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Autorzy :
Henss L; Paul-Ehrlich-Institut, Department of Virology, Langen, Germany.
Scholz T; Paul-Ehrlich-Institut, Department of Virology, Langen, Germany.
von Rhein C; Paul-Ehrlich-Institut, Department of Virology, Langen, Germany.
Wieters I; Zentrum für Innere Medizin, Infektiologie, Universitätsklinikum Frankfurt, Goethe Universität Frankfurt, Frankfurt am Main, Germany.
Borgans F; Zentrum für Innere Medizin, Infektiologie, Universitätsklinikum Frankfurt, Goethe Universität Frankfurt, Frankfurt am Main, Germany.
Eberhardt FJ; Zentrum für Innere Medizin, Infektiologie, Universitätsklinikum Frankfurt, Goethe Universität Frankfurt, Frankfurt am Main, Germany.
Zacharowski K; Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum Frankfurt, Frankfurt am Main, Germany.
Ciesek S; Institut für Medizinische Virologie, Universitätsklinikum Frankfurt am Main, Goethe Universität Frankfurt, Frankfurt am Main, Germany.
Rohde G; Medizinische Klinik 1, Pneumologie/Allergologie, Universitätsklinikum Frankfurt-Goethe-Universität, Frankfurt am Main, Germany.
Vehreschild M; Zentrum für Innere Medizin, Infektiologie, Universitätsklinikum Frankfurt, Goethe Universität Frankfurt, Frankfurt am Main, Germany.
Stephan C; Zentrum für Innere Medizin, Infektiologie, Universitätsklinikum Frankfurt, Goethe Universität Frankfurt, Frankfurt am Main, Germany.
Wolf T; Zentrum für Innere Medizin, Infektiologie, Universitätsklinikum Frankfurt, Goethe Universität Frankfurt, Frankfurt am Main, Germany.
Hofmann-Winkler H; Deutsches Primatenzentrum GmbH, Leibniz-Institut für Primatenforschung, Göttingen, Germany.
Scheiblauer H; Paul-Ehrlich-Institut, IVD, Langen, Germany.
Schnierle BS; Paul-Ehrlich-Institut, Department of Virology, Langen, Germany.
Pokaż więcej
Źródło :
The Journal of infectious diseases [J Infect Dis] 2021 Jan 04; Vol. 223 (1), pp. 56-61.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunity, Humoral*
Antibodies, Viral/*immunology
COVID-19/*immunology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antibodies, Neutralizing/immunology ; Cohort Studies ; Cross Reactions ; Enzyme-Linked Immunosorbent Assay ; Female ; Germany ; HEK293 Cells ; Humans ; Immunoglobulin A/immunology ; Immunoglobulin G/immunology ; Male ; Middle Aged ; Young Adult
Czasopismo naukowe
Tytuł :
Longitudinal transcriptome analyses show robust T cell immunity during recovery from COVID-19.
Autorzy :
Zheng HY; Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences and Yunnan Province, KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases, Center for Biosafety Mega-Science, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, 650223, China.
Xu M; Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences and Yunnan Province, KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases, Center for Biosafety Mega-Science, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, 650223, China.
Yang CX; Yunnan Infectious Disease Hospital, Kunming, 650301, China.
Tian RR; Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences and Yunnan Province, KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases, Center for Biosafety Mega-Science, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, 650223, China.
Zhang M; Yunnan Infectious Disease Hospital, Kunming, 650301, China.
Li JJ; Yunnan Infectious Disease Hospital, Kunming, 650301, China.
Wang XC; Yunnan Infectious Disease Hospital, Kunming, 650301, China.
Ding ZL; Kunming Biological Diversity Regional Center of Large Apparatus and Equipments, Public Technical Service Center, Chinese Academy of Sciences, Kunming, Yunnan, 650223, China.
Li GM; Kunming Biological Diversity Regional Center of Large Apparatus and Equipments, Public Technical Service Center, Chinese Academy of Sciences, Kunming, Yunnan, 650223, China.
Li XL; Kunming Biological Diversity Regional Center of Large Apparatus and Equipments, Public Technical Service Center, Chinese Academy of Sciences, Kunming, Yunnan, 650223, China.
He YQ; Kunming Biological Diversity Regional Center of Large Apparatus and Equipments, Public Technical Service Center, Chinese Academy of Sciences, Kunming, Yunnan, 650223, China.
Dong XQ; Yunnan Infectious Disease Hospital, Kunming, 650301, China. .
Yao YG; Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences and Yunnan Province, KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases, Center for Biosafety Mega-Science, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, 650223, China. .; Kunming College of Life Science, University of Chinese Academy of Sciences, Kunming, Yunnan, 650204, China. .; CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, 200031, China. .
Zheng YT; Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences and Yunnan Province, KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases, Center for Biosafety Mega-Science, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, 650223, China. .; Kunming College of Life Science, University of Chinese Academy of Sciences, Kunming, Yunnan, 650204, China. .
Pokaż więcej
Źródło :
Signal transduction and targeted therapy [Signal Transduct Target Ther] 2020 Dec 24; Vol. 5 (1), pp. 294. Date of Electronic Publication: 2020 Dec 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19/*genetics
Immunity, Humoral/*genetics
T-Lymphocytes/*metabolism
Transcriptome/*genetics
COVID-19/epidemiology ; COVID-19/pathology ; Female ; Humans ; Immunity, Humoral/immunology ; Leukocytes, Mononuclear/metabolism ; Male ; MicroRNAs ; RNA, Long Noncoding/genetics ; RNA-Seq ; SARS-CoV-2/genetics ; SARS-CoV-2/pathogenicity ; T-Lymphocytes/immunology ; T-Lymphocytes/pathology ; Transcription Factor AP-1/genetics
Czasopismo naukowe
Tytuł :
State of humoral immunity and cytokine profile in rats under experimental carcinogenesis with applying enterosorporation chemotherapeutic factors.
Autorzy :
Kachur O; I. Horbachevsky Ternopil National Medical University, Ukraine: Department of General Chemistry.
Fira L; I. Horbachevsky Ternopil National Medical University, Ukraine: Department of Medical Biochemistry.
Lykhatskyi P; I. Horbachevsky Ternopil National Medical University, Ukraine: Department of Medical Biochemistry.
Fira D; I. Horbachevsky Ternopil National Medical University, Ukraine: Department of General Surgery.
Kramar S; I. Horbachevsky Ternopil National Medical University, Ukraine: Department of Histology and Embryology.
Pokaż więcej
Źródło :
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego [Pol Merkur Lekarski] 2020 Dec 22; Vol. 48 (288), pp. 431-436.
Typ publikacji :
Journal Article
MeSH Terms :
Colonic Neoplasms*/chemically induced
Colonic Neoplasms*/drug therapy
Immunity, Humoral*
1,2-Dimethylhydrazine/toxicity ; Animals ; Carcinogenesis ; Colon ; Cytokines ; Humans ; Rats
Czasopismo naukowe
Tytuł :
Humoral Responses and Serological Assays in SARS-CoV-2 Infections.
Autorzy :
Galipeau Y; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
Greig M; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
Liu G; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
Driedger M; The Ottawa Hospital, Ottawa, ON, Canada.
Langlois MA; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.; uOttawa Center for Infection, Immunity and Inflammation (CI3), Ottawa, ON, Canada.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2020 Dec 18; Vol. 11, pp. 610688. Date of Electronic Publication: 2020 Dec 18 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
COVID-19*/diagnosis
COVID-19*/epidemiology
COVID-19*/immunology
COVID-19 Serological Testing*
Immunity, Humoral*
Models, Immunological*
Pandemics*
Antibodies, Viral/*immunology
SARS-CoV-2/*immunology
Humans
Czasopismo naukowe
Tytuł :
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report.
Autorzy :
Buckland MS; Department of Clinical Immunology, Barts Health, London, UK. .; UCL GOSH Institute of Child Health Division of Infection and Immunity, Section of Cellular and Molecular Immunology, London, UK. .
Galloway JB; Centre for Rheumatic Diseases, King's College London, London, UK.
Fhogartaigh CN; Department of Infection, Barts Health NHS Trust, London, UK.
Meredith L; Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
Provine NM; Peter Medawar Building for Pathogen Research, South Parks Rd, Oxford, OX1 3SY, UK.; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Bloor S; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Ogbe A; Peter Medawar Building for Pathogen Research, South Parks Rd, Oxford, OX1 3SY, UK.; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Zelek WM; Systems Immunity Institute and Dementia Research Institute, Cardiff University, Cardiff, UK.
Smielewska A; Division of Virology, Department of Pathology, University of Cambridge, Addenbrookes Hospital, Cambridge, UK.; PHE - Public Health England Laboratory, Cambridge. Box 236, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK.
Yakovleva A; Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
Mann T; Medical Research Council Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge, CB2 1QW, UK.
Bergamaschi L; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Turner L; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Mescia F; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Toonen EJM; R&D Department, Hycult Biotechnology, Frontstraat 2A, 5405 PB, Uden, The Netherlands.
Hackstein CP; Peter Medawar Building for Pathogen Research, South Parks Rd, Oxford, OX1 3SY, UK.; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Akther HD; Peter Medawar Building for Pathogen Research, South Parks Rd, Oxford, OX1 3SY, UK.; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Vieira VA; Peter Medawar Building for Pathogen Research, South Parks Rd, Oxford, OX1 3SY, UK.; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Ceron-Gutierrez L; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.
Periselneris J; Respiratory Department, King's College Hospital NHS Foundation Trust, UK. Department of Clinical Virology, Addenbrookes, UK.
Kiani-Alikhan S; Department of Clinical Immunology, Barts Health, London, UK.
Grigoriadou S; Department of Clinical Immunology, Barts Health, London, UK.
Vaghela D; Department of Infectious Diseases, Cambridge University Hospitals NHS Trust, Cambridge, UK.
Lear SE; Department of Immunology, Cambridge University Hospitals NHS Trust, Cambridge, UK.
Török ME; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Cambridge University Hospitals NHS Foundation Trust, Department of Microbiology, Cambridge, UK.
Hamilton WL; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Stockton J; Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
Quick J; Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
Nelson P; Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.
Hunter M; Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.
Coulter TI; Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.; Regional Immunology Service, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.
Devlin L; Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.; Regional Immunology Service, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.
Bradley JR; NIHR BioResource and NIHR Cambridge Biomedical Research Centre, Cambridge Biomedical Campus, Cambridge, UK.
Smith KGC; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Ouwehand WH; Department of Haematology, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.; NHS Blood and Transplant, Cambridge Biomedical Campus, Cambridge, UK.
Estcourt L; NHS Blood and Transplant, Oxford, UK.
Harvala H; NHS Blood and Transplant, London, UK.
Roberts DJ; NHS Blood and Transplant, Oxford, UK.; Radcliffe Department of Medicine and BRC Haematology Theme, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Wilkinson IB; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Screaton N; Radiology, Papworth Hospital, Cambridge, UK.
Loman N; Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
Doffinger R; Respiratory Department, King's College Hospital NHS Foundation Trust, UK. Department of Clinical Virology, Addenbrookes, UK.
Lyons PA; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Morgan BP; Systems Immunity Institute and Dementia Research Institute, Cardiff University, Cardiff, UK.
Goodfellow IG; Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
Klenerman P; Peter Medawar Building for Pathogen Research, South Parks Rd, Oxford, OX1 3SY, UK.; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Lehner PJ; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.; Department of Infectious Diseases, Cambridge University Hospitals NHS Trust, Cambridge, UK.
Matheson NJ; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK. .; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK. .; Department of Infectious Diseases, Cambridge University Hospitals NHS Trust, Cambridge, UK. .; NHS Blood and Transplant, Cambridge Biomedical Campus, Cambridge, UK. .
Thaventhiran JED; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK. .; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK. .; Medical Research Council Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge, CB2 1QW, UK. .; Cancer Research UK Cambridge Institute, Cambridge Biomedical Campus, Cambridge, UK. .
Pokaż więcej
Corporate Authors :
CITIID-NIHR COVID-19 BioResource Collaboration
MRC-Toxicology Unit COVID-19 Consortium
Źródło :
Nature communications [Nat Commun] 2020 Dec 14; Vol. 11 (1), pp. 6385. Date of Electronic Publication: 2020 Dec 14.
Typ publikacji :
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenosine Monophosphate/*analogs & derivatives
Alanine/*analogs & derivatives
Immunity, Humoral/*drug effects
SARS-CoV-2/*drug effects
Adenosine Monophosphate/therapeutic use ; Adult ; Alanine/therapeutic use ; Antiviral Agents/therapeutic use ; COVID-19/virology ; Fever/prevention & control ; Humans ; Immunity, Humoral/immunology ; Lymphocyte Count ; Male ; SARS-CoV-2/immunology ; SARS-CoV-2/physiology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.
Autorzy :
Ng KW; Retroviral Immunology, The Francis Crick Institute, London NW1 1AT, UK.
Faulkner N; Retroviral Immunology, The Francis Crick Institute, London NW1 1AT, UK.
Cornish GH; Retroviral Immunology, The Francis Crick Institute, London NW1 1AT, UK.
Rosa A; Chromatin Structure and Mobile DNA Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
Harvey R; Worldwide Influenza Centre, The Francis Crick Institute, London NW1 1AT, UK.
Hussain S; Worldwide Influenza Centre, The Francis Crick Institute, London NW1 1AT, UK.
Ulferts R; Cell Biology of Infection Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
Earl C; Signalling and Structural Biology Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
Wrobel AG; Structural Biology of Disease Processes Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
Benton DJ; Structural Biology of Disease Processes Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
Roustan C; Structural Biology STP, The Francis Crick Institute, London NW1 1AT, UK.
Bolland W; Retroviral Immunology, The Francis Crick Institute, London NW1 1AT, UK.
Thompson R; Retroviral Immunology, The Francis Crick Institute, London NW1 1AT, UK.
Agua-Doce A; Flow Cytometry STP, The Francis Crick Institute, London NW1 1AT, UK.
Hobson P; Flow Cytometry STP, The Francis Crick Institute, London NW1 1AT, UK.
Heaney J; University College London Hospitals (UCLH) NHS Trust, London NW1 2BU, UK.
Rickman H; University College London Hospitals (UCLH) NHS Trust, London NW1 2BU, UK.
Paraskevopoulou S; University College London Hospitals (UCLH) NHS Trust, London NW1 2BU, UK.
Houlihan CF; University College London Hospitals (UCLH) NHS Trust, London NW1 2BU, UK.; Division of Infection and Immunity, University College London (UCL), London WC1E 6BT, UK.
Thomson K; University College London Hospitals (UCLH) NHS Trust, London NW1 2BU, UK.
Sanchez E; University College London Hospitals (UCLH) NHS Trust, London NW1 2BU, UK.
Shin GY; University College London Hospitals (UCLH) NHS Trust, London NW1 2BU, UK.
Spyer MJ; University College London Hospitals (UCLH) NHS Trust, London NW1 2BU, UK.; Department of Population, Policy and Practice, Great Ormond Street Institute for Child Health (ICH), UCL, London WC1N 1EH, UK.
Joshi D; Peptide Chemistry, The Francis Crick Institute, London NW1 1AT, UK.
O'Reilly N; Peptide Chemistry, The Francis Crick Institute, London NW1 1AT, UK.
Walker PA; Structural Biology STP, The Francis Crick Institute, London NW1 1AT, UK.
Kjaer S; Structural Biology STP, The Francis Crick Institute, London NW1 1AT, UK.
Riddell A; Flow Cytometry STP, The Francis Crick Institute, London NW1 1AT, UK.
Moore C; Public Health Wales, University Hospital of Wales, Cardiff CF14 4XW, UK.
Jebson BR; Centre for Adolescent Rheumatology Versus Arthritis at UCL, UCLH, Great Ormond Street Hospital (GOSH), London WC1N 3JH, UK.; UCL Great Ormond Street Institute for Child Health (ICH), UCL, London WC1N 1EH, UK.
Wilkinson M; Centre for Adolescent Rheumatology Versus Arthritis at UCL, UCLH, Great Ormond Street Hospital (GOSH), London WC1N 3JH, UK.; UCL Great Ormond Street Institute for Child Health (ICH), UCL, London WC1N 1EH, UK.
Marshall LR; Centre for Adolescent Rheumatology Versus Arthritis at UCL, UCLH, Great Ormond Street Hospital (GOSH), London WC1N 3JH, UK.; UCL Great Ormond Street Institute for Child Health (ICH), UCL, London WC1N 1EH, UK.
Rosser EC; Centre for Adolescent Rheumatology Versus Arthritis at UCL, UCLH, Great Ormond Street Hospital (GOSH), London WC1N 3JH, UK.; Centre for Rheumatology Research, Division of Medicine, UCL, London, WC1E 6BT, UK.
Radziszewska A; Centre for Adolescent Rheumatology Versus Arthritis at UCL, UCLH, Great Ormond Street Hospital (GOSH), London WC1N 3JH, UK.; Centre for Rheumatology Research, Division of Medicine, UCL, London, WC1E 6BT, UK.
Peckham H; Centre for Adolescent Rheumatology Versus Arthritis at UCL, UCLH, Great Ormond Street Hospital (GOSH), London WC1N 3JH, UK.; Centre for Rheumatology Research, Division of Medicine, UCL, London, WC1E 6BT, UK.
Ciurtin C; Centre for Adolescent Rheumatology Versus Arthritis at UCL, UCLH, Great Ormond Street Hospital (GOSH), London WC1N 3JH, UK.; Centre for Rheumatology Research, Division of Medicine, UCL, London, WC1E 6BT, UK.
Wedderburn LR; Centre for Adolescent Rheumatology Versus Arthritis at UCL, UCLH, Great Ormond Street Hospital (GOSH), London WC1N 3JH, UK.; UCL Great Ormond Street Institute for Child Health (ICH), UCL, London WC1N 1EH, UK.
Beale R; Cell Biology of Infection Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
Gandhi S; Neurodegeneration Biology Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
Stockinger B; AhRimmunity Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
McCauley J; Worldwide Influenza Centre, The Francis Crick Institute, London NW1 1AT, UK.
Gamblin SJ; Structural Biology of Disease Processes Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
McCoy LE; Division of Infection and Immunity, University College London (UCL), London WC1E 6BT, UK. .
Cherepanov P; Chromatin Structure and Mobile DNA Laboratory, The Francis Crick Institute, London NW1 1AT, UK. .
Nastouli E; University College London Hospitals (UCLH) NHS Trust, London NW1 2BU, UK. .; Department of Population, Policy and Practice, Great Ormond Street Institute for Child Health (ICH), UCL, London WC1N 1EH, UK.
Kassiotis G; Retroviral Immunology, The Francis Crick Institute, London NW1 1AT, UK. .; Department of Medicine, Faculty of Medicine, Imperial College London, London W2 1PG, UK.
Pokaż więcej
Źródło :
Science (New York, N.Y.) [Science] 2020 Dec 11; Vol. 370 (6522), pp. 1339-1343. Date of Electronic Publication: 2020 Nov 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunity, Humoral*
Antibodies, Viral/*blood
COVID-19/*immunology
SARS-CoV-2/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Adult ; Aged ; Aged, 80 and over ; Amino Acid Sequence ; Animals ; COVID-19/blood ; Epitope Mapping ; Female ; HEK293 Cells ; Humans ; Immunoglobulin A/blood ; Immunoglobulin G/blood ; Immunoglobulin M/blood ; Male ; Middle Aged ; SARS-CoV-2/chemistry ; Spike Glycoprotein, Coronavirus/chemistry ; Viral Zoonoses/blood ; Viral Zoonoses/immunology ; Young Adult
Czasopismo naukowe
Tytuł :
Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality.
Autorzy :
Zohar T; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Loos C; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Fischinger S; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA; PhD Program in Immunology and Virology, University of Duisburg-Essen, Essen, Germany.
Atyeo C; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA; PhD Program in Virology, Division of Medical Sciences, Harvard University, Boston, MA, USA.
Wang C; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Slein MD; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
Burke J; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
Yu J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard, Medical School, Boston, MA 02215, USA.
Feldman J; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
Hauser BM; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
Caradonna T; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
Schmidt AG; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
Cai Y; Division of Molecular Medicine, Boston Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
Streeck H; Institute of Virology, University Hospital, University of Bonn and German Center for Infection Research (DZIF), Bonn-Cologne, Bonn, Germany.
Ryan ET; Infectious Disease Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard, Medical School, Boston, MA 02215, USA.
Charles RC; Infectious Disease Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: .
Lauffenburger DA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. Electronic address: .
Alter G; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA. Electronic address: .
Pokaż więcej
Źródło :
Cell [Cell] 2020 Dec 10; Vol. 183 (6), pp. 1508-1519.e12. Date of Electronic Publication: 2020 Nov 03.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
COVID-19*/immunology
COVID-19*/mortality
Immunity, Humoral*
Immunoglobulin A/*immunology
Immunoglobulin M/*immunology
Receptors, IgG/*immunology
SARS-CoV-2/*immunology
Female ; HL-60 Cells ; Humans ; Male
Czasopismo naukowe
Tytuł :
Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients.
Autorzy :
Hashem AM; Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.; Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Algaissi A; Department of Medical Laboratories Technology, College of Applied Medical Sciences, Jazan University, Jazan 45142, Saudi Arabia.; Medical Research Center, Jazan University, Jazan 45142, Saudi Arabia.
Almahboub SA; Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Alfaleh MA; Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.; Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Abujamel TS; Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.; Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Alamri SS; Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.; Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Alluhaybi KA; Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.; Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Hobani HI; Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
AlHarbi RH; Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Alsulaiman RM; Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
ElAssouli MZ; Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Hala S; King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Jeddah 11426, Saudi Arabia.
Alharbi NK; King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh 14611, Saudi Arabia.
Alhabbab RY; Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.; Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
AlSaieedi AA; Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.; Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Abdulaal WH; Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Bukhari A; Department of Medicine, Faculty of Medicine, Imam Mohammed Ibn Saud Islamic University, Riyadh 11432, Saudi Arabia.
Al-Somali AA; Infectious Diseases Department, King Abdullah Medical Complex, Jeddah 24246, Saudi Arabia.
Alofi FS; Infectious Diseases Department, King Fahad Hospital, Almadinah Almunwarah 11525, Saudi Arabia.
Khogeer AA; Plan and Research Department, General Directorate of Health Affairs Makkah Region, Ministry of Health, Makkah 11176, Saudi Arabia.
Pain A; Pathogen Genomics Laboratory, Division of Biological and Environmental Sciences and Engineering (BESE), Thuwal 23955, Saudi Arabia.; Research Center for Zoonosis Control, Hokkaido University, N20 W10, Kita-ku, Sapporo 001-0030, Japan.; Nuffield Division of Clinical Laboratory Sciences (NDCLS), University of Oxford, Oxford OX3 9DU, UK.
Alkayyal AA; Department of Medical Laboratory Technology, University of Tabuk, Tabuk 71491, Saudi Arabi.; Immunology Research Program, King Abdullah International Medical Research Center, Riyadh 14611, Saudi Arabia.
Almontashiri NAM; Center for Genetics and Inherited Diseases, Taibah University, Almadinah Almunwarah 71491, Saudi Arabia.
Ahmad BM; Immunology Research Program, King Abdullah International Medical Research Center, Riyadh 14611, Saudi Arabia.; College of Applied Medical Sciences, Taibah University, Almadinah Almunwarah 71491, Saudi Arabia.
Li X; Centre for Biologics Evaluation, Biologics and Genetic Therapies Directorate, Health Products and Food Branch (HPFB), Health Canada and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Ottawa, ON K1A 0K9, Canada.; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Pokaż więcej
Źródło :
Viruses [Viruses] 2020 Dec 04; Vol. 12 (12). Date of Electronic Publication: 2020 Dec 04.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunity, Humoral*
Antibodies, Viral/*blood
COVID-19/*immunology
Immunoglobulin G/*blood
Antibodies, Neutralizing/blood ; COVID-19/diagnosis ; Hospitalization ; Humans ; Immunoglobulin M/blood ; Kinetics ; Longitudinal Studies ; Neutralization Tests ; Nucleocapsid Proteins/immunology ; Severity of Illness Index ; Spike Glycoprotein, Coronavirus/immunology
Czasopismo naukowe
Tytuł :
B careful: Humoral responses and COVID-19 severity.
Autorzy :
Fanous H; Department of Pediatrics, University of Miami School of Medicine, Miami, FL, USA.
Guerrero-Pena A; Department of Pediatrics, University of Miami School of Medicine, Miami, FL, USA.
Pillai A; Department of Pediatrics, University of Miami School of Medicine, Miami, FL, USA. .
Pokaż więcej
Źródło :
Science immunology [Sci Immunol] 2020 Dec 04; Vol. 5 (54).
Typ publikacji :
Journal Article
MeSH Terms :
Immunity, Humoral*
Antibodies, Neutralizing/*immunology
Antibodies, Viral/*immunology
COVID-19/*immunology
SARS-CoV-2/*immunology
Antibodies, Neutralizing/blood ; Antibodies, Viral/blood ; B-Lymphocytes/immunology ; B-Lymphocytes/virology ; C-Reactive Protein/immunology ; COVID-19/epidemiology ; COVID-19/virology ; Humans ; Pandemics ; SARS-CoV-2/physiology ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Durability of humoral immune responses to rubella following MMR vaccination.
Autorzy :
Crooke SN; Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.
Riggenbach MM; Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.
Ovsyannikova IG; Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.
Warner ND; Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
Chen MH; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Hao L; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Icenogle JP; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Poland GA; Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.
Kennedy RB; Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2020 Dec 03; Vol. 38 (51), pp. 8185-8193. Date of Electronic Publication: 2020 Nov 12.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunity, Humoral*
Measles-Mumps-Rubella Vaccine/*immunology
Rubella/*immunology
Adolescent ; Adult ; Antibodies, Neutralizing/immunology ; B-Lymphocytes/immunology ; Female ; Humans ; Immunoglobulin G/blood ; Male ; Measles-Mumps-Rubella Vaccine/pharmacology ; Rubella/prevention & control ; Time Factors ; Vaccination ; Young Adult
Czasopismo naukowe
Tytuł :
Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients.
Autorzy :
Mazzoni A; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Maggi L; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Capone M; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Spinicci M; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.
Salvati L; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Colao MG; Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy.
Vanni A; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Kiros ST; Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy.
Mencarini J; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.
Zammarchi L; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.
Mantengoli E; Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.
Menicacci L; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Caldini E; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Romagnani S; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Liotta F; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Immunology and Cell Therapy Unit, Careggi University Hospital, Florence, Italy.
Morettini A; Internal Medicine 2 Unit, Careggi University Hospital, Florence, Italy.
Rossolini GM; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy.
Bartoloni A; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.
Cosmi L; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Immunology and Cell Therapy Unit, Careggi University Hospital, Florence, Italy.
Annunziato F; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Flow Cytometry Diagnostic Center and Immunotherapy (CDCI), Careggi University Hospital, Florence, Italy.
Pokaż więcej
Źródło :
European journal of immunology [Eur J Immunol] 2020 Dec; Vol. 50 (12), pp. 2013-2024. Date of Electronic Publication: 2020 Nov 09.
Typ publikacji :
Clinical Trial; Journal Article
MeSH Terms :
Immunity, Humoral*
Antibodies, Viral/*immunology
COVID-19/*immunology
Carrier State/*immunology
SARS-CoV-2/*immunology
T-Lymphocytes/*immunology
Adult ; Carrier State/virology ; Female ; Humans ; Programmed Cell Death 1 Receptor/immunology ; Receptors, Immunologic/immunology ; Viral Proteins/immunology
Czasopismo naukowe
Tytuł :
Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect.
Autorzy :
Maine GN; Department of Pathology and Laboratory Medicine, Beaumont Health, Royal Oak, MI, USA; Department of Pathology and Laboratory Medicine, Oakland University William Beaumont School of Medicine, Auburn Hills, MI, USA. Electronic address: .
Lao KM; Department of Pathology and Laboratory Medicine, Beaumont Health, Royal Oak, MI, USA.
Krishnan SM; Department of Pathology and Laboratory Medicine, Beaumont Health, Royal Oak, MI, USA.
Afolayan-Oloye O; Department of Pathology and Laboratory Medicine, Beaumont Health, Royal Oak, MI, USA.
Fatemi S; Department of Pathology and Laboratory Medicine, Beaumont Health, Royal Oak, MI, USA.
Kumar S; Department of Pathology and Laboratory Medicine, Beaumont Health, Royal Oak, MI, USA.
VanHorn L; Department of Pathology and Laboratory Medicine, Beaumont Health, Royal Oak, MI, USA.
Hurand A; Department of Pathology and Laboratory Medicine, Beaumont Health, Royal Oak, MI, USA.
Sykes E; Department of Pathology and Laboratory Medicine, Beaumont Health, Royal Oak, MI, USA; Department of Pathology and Laboratory Medicine, Oakland University William Beaumont School of Medicine, Auburn Hills, MI, USA.
Sun Q; Department of Pathology and Laboratory Medicine, Beaumont Health, Royal Oak, MI, USA; Department of Pathology and Laboratory Medicine, Oakland University William Beaumont School of Medicine, Auburn Hills, MI, USA. Electronic address: .
Pokaż więcej
Źródło :
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [J Clin Virol] 2020 Dec; Vol. 133, pp. 104663. Date of Electronic Publication: 2020 Oct 27.
Typ publikacji :
Evaluation Study; Journal Article
MeSH Terms :
COVID-19 Serological Testing*
Immunity, Humoral*
Antibodies, Viral/*blood
COVID-19/*diagnosis
Immunoglobulin G/*blood
Immunoglobulin M/*blood
COVID-19/immunology ; Cohort Studies ; Humans ; Longitudinal Studies ; Reproducibility of Results ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity.
Autorzy :
Ripperger TJ; Department of Immunobiology, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
Uhrlaub JL; Department of Immunobiology, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA; University of Arizona Center on Aging, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
Watanabe M; Department of Immunobiology, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA; University of Arizona Center on Aging, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
Wong R; Department of Immunobiology, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA; Division of Biological and Biomedical Sciences, Washington University, St. Louis, MO, USA.
Castaneda Y; Department of Immunobiology, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA; University of Arizona Center on Aging, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
Pizzato HA; Department of Immunobiology, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA; Division of Biological and Biomedical Sciences, Washington University, St. Louis, MO, USA.
Thompson MR; Department of Surgery, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA; Department of Cellular and Molecular Medicine, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
Bradshaw C; Department of Immunobiology, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA; University of Arizona Center on Aging, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
Weinkauf CC; Department of Surgery, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
Bime C; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
Erickson HL; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
Knox K; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA; Department of Medicine, University of Arizona, Phoenix, Phoenix, AZ, USA.
Bixby B; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
Parthasarathy S; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
Chaudhary S; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
Natt B; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
Cristan E; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
El Aini T; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
Rischard F; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
Campion J; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
Chopra M; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
Insel M; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
Sam A; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
Knepler JL; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
Capaldi AP; Department of Molecular and Cellular Biology, University of Arizona, Tucson, Tucson, AZ, USA; Functional Genomics Core, University of Arizona, Tucson, AZ, USA.
Spier CM; Department of Pathology, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
Dake MD; Office of the Senior Vice-President for Health Sciences, University of Arizona, Tucson, AZ, USA.
Edwards T; University of Arizona Genomics Core and the Arizona Research Labs, University of Arizona Genetics Core, University of Arizona, Tucson, AZ, USA.
Kaplan ME; Functional Genomics Core, University of Arizona, Tucson, AZ, USA.
Scott SJ; Division of Geriatrics, General Medicine and Palliative Care, Department of Medicine, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
Hypes C; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA; Department of Emergency Medicine, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
Mosier J; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA; Department of Emergency Medicine, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
Harris DT; Department of Immunobiology, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA; University of Arizona Health Sciences Biobank, University of Arizona, Tucson, AZ, USA.
LaFleur BJ; BIO5 Institute, University of Arizona, Tucson, AZ, USA.
Sprissler R; University of Arizona Genomics Core and the Arizona Research Labs, University of Arizona Genetics Core, University of Arizona, Tucson, AZ, USA; BIO5 Institute, University of Arizona, Tucson, AZ, USA.
Nikolich-Žugich J; Department of Immunobiology, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA; University of Arizona Center on Aging, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA; BIO5 Institute, University of Arizona, Tucson, AZ, USA. Electronic address: .
Bhattacharya D; Department of Immunobiology, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA; BIO5 Institute, University of Arizona, Tucson, AZ, USA. Electronic address: .
Pokaż więcej
Źródło :
Immunity [Immunity] 2020 Nov 17; Vol. 53 (5), pp. 925-933.e4. Date of Electronic Publication: 2020 Oct 14.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Immunity, Humoral*
Betacoronavirus/*immunology
Clinical Laboratory Techniques/*methods
Coronavirus Infections/*epidemiology
Coronavirus Infections/*immunology
Pneumonia, Viral/*epidemiology
Pneumonia, Viral/*immunology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antibodies, Neutralizing/blood ; Antibodies, Viral/blood ; Arizona/epidemiology ; Betacoronavirus/isolation & purification ; COVID-19 ; COVID-19 Testing ; Coronavirus Infections/blood ; Coronavirus Infections/diagnosis ; Coronavirus Nucleocapsid Proteins ; Female ; Humans ; Male ; Middle Aged ; Nucleocapsid Proteins/immunology ; Pandemics ; Phosphoproteins ; Pneumonia, Viral/blood ; Pneumonia, Viral/diagnosis ; Prevalence ; Protein Interaction Domains and Motifs ; SARS-CoV-2 ; Seroepidemiologic Studies ; Spike Glycoprotein, Coronavirus/chemistry ; Spike Glycoprotein, Coronavirus/immunology ; Young Adult
Czasopismo naukowe
Tytuł :
 
Autorzy :
Fumeaux T; Service de médecine et des soins intensifs, Hôpital de Nyon.
Pokaż więcej
Transliterated Title :
Covid-19: que sait-on de la réponse immune humorale au virus SARS-CoV-2 ?
Źródło :
Revue medicale suisse [Rev Med Suisse] 2020 Nov 11; Vol. 16 (714), pp. 2190.
Typ publikacji :
Wiadomości
MeSH Terms :
Immunity, Humoral*
Betacoronavirus/*immunology
Coronavirus Infections/*immunology
Coronavirus Infections/*virology
Pneumonia, Viral/*immunology
Pneumonia, Viral/*virology
COVID-19 ; Humans ; Pandemics ; SARS-CoV-2
Periodyk
Tytuł :
Short- and long-term humoral immune response against Yersinia pestis in plague patients, Madagascar.
Autorzy :
Andrianaivoarimanana V; Plague Unit, Institut Pasteur de Madagascar, 101, Antananarivo, Madagascar. .
Iharisoa AL; Plague Unit, Institut Pasteur de Madagascar, 101, Antananarivo, Madagascar.
Rahalison L; Plague Unit, Institut Pasteur de Madagascar, 101, Antananarivo, Madagascar.
Ralimanantsoa ML; Central Laboratory for Plague, Ministry of Public Health, 101, Antananarivo, Madagascar.
Ratsitorahina M; Epidemiology Unit, Institut Pasteur de Madagascar, 101, Antananarivo, Madagascar.
Rakotonanahary RJL; Plague Unit, Institut Pasteur de Madagascar, 101, Antananarivo, Madagascar.
Carniel E; Yersinia Research Unit, Institut Pasteur, 75724, Paris, France.
Demeure C; Yersinia Research Unit, Institut Pasteur, 75724, Paris, France.
Rajerison M; Plague Unit, Institut Pasteur de Madagascar, 101, Antananarivo, Madagascar.
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2020 Nov 10; Vol. 20 (1), pp. 822. Date of Electronic Publication: 2020 Nov 10.
Typ publikacji :
Journal Article
MeSH Terms :
Immunity, Humoral*
Plague/*immunology
Yersinia pestis/*immunology
Adolescent ; Adult ; Animals ; Antibodies, Bacterial/blood ; Antigens, Bacterial/immunology ; Bacterial Proteins/immunology ; Child ; Female ; Follow-Up Studies ; Humans ; Immunoglobulin G/blood ; Madagascar/epidemiology ; Male ; Plague/epidemiology ; Plague/microbiology ; Prospective Studies ; Retrospective Studies ; Seroepidemiologic Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Evidence of potent humoral immune activity in COVID-19-infected kidney transplant recipients.
Autorzy :
Hartzell S; Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Bin S; Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Benedetti C; Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Haverly M; Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Gallon L; Department of Medicine, Division of Nephrology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Zaza G; Renal Unit, Department of Medicine, University Hospital of Verona, Verona, Italy.
Riella LV; Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Menon MC; Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Florman S; Recanati-Miller Transplantation Institute, Mount Sinai Hospital, New York, New York, USA.
Rahman AH; Human Immune Monitoring Core, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Leech JM; Human Immune Monitoring Core, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Heeger PS; Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Cravedi P; Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Pokaż więcej
Źródło :
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2020 Nov; Vol. 20 (11), pp. 3149-3161. Date of Electronic Publication: 2020 Oct 02.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Immunity, Humoral*
Immunocompromised Host*
Pandemics*
Transplant Recipients*
COVID-19/*epidemiology
Kidney Transplantation/*adverse effects
Renal Insufficiency/*epidemiology
CD8-Positive T-Lymphocytes/immunology ; COVID-19/immunology ; Comorbidity ; Female ; Humans ; Male ; Middle Aged ; Renal Insufficiency/surgery ; Retrospective Studies ; SARS-CoV-2 ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Antibody Responses to SARS-CoV-2: Let's Stick to Known Knowns.
Autorzy :
Baumgarth N; Center for Immunology and Infectious Diseases, Department of Pathology, Microbiology and Immunology, University of California, Davis, Davis, CA 95616.
Nikolich-Žugich J; Department of Immunobiology, University of Arizona College of Medicine-Tucson, Tucson, AZ 85724.; University of Arizona Center on Aging, University of Arizona College of Medicine-Tucson, Tucson, AZ 85724.
Lee FE; Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA 30322.; Lowance Center for Human Immunology, Department of Medicine, Emory University, Atlanta, GA 30322; and.; Lowance Center for Human Immunology, Department of Pediatrics, Emory University, Atlanta, GA 30322.
Bhattacharya D; Department of Immunobiology, University of Arizona College of Medicine-Tucson, Tucson, AZ 85724; .
Pokaż więcej
Źródło :
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2020 Nov 01; Vol. 205 (9), pp. 2342-2350. Date of Electronic Publication: 2020 Sep 04.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms :
Immunity, Humoral*
Antibodies, Viral/*immunology
Betacoronavirus/*immunology
Coronavirus Infections/*epidemiology
Coronavirus Infections/*immunology
Pneumonia, Viral/*epidemiology
Pneumonia, Viral/*immunology
Adult ; Aged ; Antibodies, Neutralizing/immunology ; B-Lymphocytes/immunology ; Betacoronavirus/genetics ; COVID-19 ; COVID-19 Testing ; Clinical Laboratory Techniques ; Coronavirus Infections/diagnosis ; Coronavirus Infections/virology ; Humans ; Immunologic Memory ; Middle Aged ; Pandemics ; Pneumonia, Viral/virology ; Polymerase Chain Reaction ; SARS-CoV-2 ; Seroconversion
Czasopismo naukowe
Tytuł :
Humoral immune response of pigs infected with Toxocara cati.
Autorzy :
Sierra MF; Universidad de Buenos Aires, Facultad de Ciencias Veterinarias, Cátedra de Salud Pública, Av. Chorroarín 280, C1427CWO, Buenos Aires, Argentina. Electronic address: .
Ricoy G; Servicio de Inmunología Parasitaria. Departamento de Parasitología, Instituto Nacional de Enfermedades Infecciosas Anlis 'Dr. Carlos G. Malbrán', Av. Vélez Sarsfield 563, C1282AFF, Buenos Aires, Argentina. Electronic address: .
Sosa S; Servicio de Inmunología Parasitaria. Departamento de Parasitología, Instituto Nacional de Enfermedades Infecciosas Anlis 'Dr. Carlos G. Malbrán', Av. Vélez Sarsfield 563, C1282AFF, Buenos Aires, Argentina. Electronic address: .
Colavecchia SB; Universidad de Buenos Aires, Facultad de Ciencias Veterinarias, Cátedra de Inmunología, Av. Chorroarín 280, C1427CWO, Buenos Aires, Argentina. Electronic address: .
Santillán G; Servicio de Inmunología Parasitaria. Departamento de Parasitología, Instituto Nacional de Enfermedades Infecciosas Anlis 'Dr. Carlos G. Malbrán', Av. Vélez Sarsfield 563, C1282AFF, Buenos Aires, Argentina. Electronic address: .
López CM; Universidad de Buenos Aires, Facultad de Ciencias Veterinarias, Cátedra de Salud Pública, Av. Chorroarín 280, C1427CWO, Buenos Aires, Argentina. Electronic address: .
Mundo SL; Universidad de Buenos Aires, Facultad de Ciencias Veterinarias, Cátedra de Inmunología, Av. Chorroarín 280, C1427CWO, Buenos Aires, Argentina. Electronic address: .
Sommerfelt IE; Universidad de Buenos Aires, Facultad de Ciencias Veterinarias, Cátedra de Salud Pública, Av. Chorroarín 280, C1427CWO, Buenos Aires, Argentina. Electronic address: .
Pokaż więcej
Źródło :
Experimental parasitology [Exp Parasitol] 2020 Nov; Vol. 218, pp. 107997. Date of Electronic Publication: 2020 Sep 15.
Typ publikacji :
Journal Article
MeSH Terms :
Immunity, Humoral*
Antibodies, Helminth/*biosynthesis
Swine Diseases/*immunology
Toxocara/*immunology
Toxocariasis/*immunology
Analysis of Variance ; Animals ; Antibodies, Helminth/blood ; Area Under Curve ; Blotting, Western ; Cats ; Disease Models, Animal ; Enzyme-Linked Immunosorbent Assay ; Feces/parasitology ; Immunoglobulin G/biosynthesis ; Immunoglobulin G/blood ; Immunoglobulin M/biosynthesis ; Immunoglobulin M/blood ; Male ; ROC Curve ; Sensitivity and Specificity ; Swine ; Swine Diseases/parasitology ; Toxocariasis/parasitology
Czasopismo naukowe
Tytuł :
Immune monitoring facilitates the clinical decision in multifocal COVID-19 of a pancreas-kidney transplant patient.
Autorzy :
Babel N; Medical Department, University Hospital Marien Hospital Herne, Ruhr-University, Bochum, Germany.; Center for Translational Medicine, University Hospital Marien Hospital Herne, Ruhr-University, Bochum, Germany.; Berlin-Brandenburg Center for Regenerative Therapies, and Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Anft M; Center for Translational Medicine, University Hospital Marien Hospital Herne, Ruhr-University, Bochum, Germany.
Blazquez-Navarro A; Center for Translational Medicine, University Hospital Marien Hospital Herne, Ruhr-University, Bochum, Germany.
Doevelaar AAN; Medical Department, University Hospital Marien Hospital Herne, Ruhr-University, Bochum, Germany.
Seibert FS; Medical Department, University Hospital Marien Hospital Herne, Ruhr-University, Bochum, Germany.
Bauer F; Medical Department, University Hospital Marien Hospital Herne, Ruhr-University, Bochum, Germany.
Rohn BJ; Medical Department, University Hospital Marien Hospital Herne, Ruhr-University, Bochum, Germany.
Hoelzer B; Medical Department, University Hospital Marien Hospital Herne, Ruhr-University, Bochum, Germany.
Thieme CJ; Berlin-Brandenburg Center for Regenerative Therapies, and Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Roch T; Center for Translational Medicine, University Hospital Marien Hospital Herne, Ruhr-University, Bochum, Germany.; Berlin-Brandenburg Center for Regenerative Therapies, and Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Meister TL; Department of Molecular and Medical Virology, Ruhr-University, Bochum, Germany.
Pfaender S; Department of Molecular and Medical Virology, Ruhr-University, Bochum, Germany.
Steinmann E; Department of Molecular and Medical Virology, Ruhr-University, Bochum, Germany.
Dittmer U; Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Schenker P; Department of Surgery, University Hospital Knappschaftskrankenhaus Bochum, Ruhr-University, Bochum, Germany.
Amann K; Department of Nephropathology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Germany.
Viebahn R; Department of Surgery, University Hospital Knappschaftskrankenhaus Bochum, Ruhr-University, Bochum, Germany.
Stervbo U; Center for Translational Medicine, University Hospital Marien Hospital Herne, Ruhr-University, Bochum, Germany.
Westhoff TH; Medical Department, University Hospital Marien Hospital Herne, Ruhr-University, Bochum, Germany.
Pokaż więcej
Źródło :
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2020 Nov; Vol. 20 (11), pp. 3210-3215. Date of Electronic Publication: 2020 Sep 09.
Typ publikacji :
Case Reports; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunity, Humoral*
Kidney Transplantation*
Antibodies, Viral/*immunology
COVID-19/*epidemiology
Monitoring, Immunologic/*methods
Pancreas Transplantation/*methods
SARS-CoV-2/*immunology
COVID-19/virology ; Clinical Decision-Making ; Comorbidity ; Graft Rejection/epidemiology ; Graft Rejection/immunology ; Humans ; Immunocompromised Host ; Pandemics
Raport

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies